Skinvisible, Inc. (OTCBB: SKVI) What Do They Do? How Do They Make Money?

Skinvisible, Inc. (OTCBB: SKVI) See StockGuru SKVI Profile

How Does Skinvisible Make Money?

Skinvisible, Inc. as a Research and Development Pharmaceutical Company that develops polymer delivery vehicles.

What does that mean? And how do they make money doing that?

Invisicare® is the name of their polymer delivery vehicle.  This is patented.

Invisicare® is used as the delivery system for topically applied skin care products.

This patented formula combines active ingredients with a delivery system that extends the duration of time the product remains on the skin and active.

Products utilizing Invisicare® have the proven ability to bond active ingredients to the skin for up to four hours and longer. This polymer deliver system – known as Invisicare® – allows normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants.  This gives SKVI a competitive edge.  No one wants an alcohol based product when there is a more effective product that is not drying like alcohol.

A protective bond is formed which resists wash-off.  Alcohol can’t do that.

So, in summary therapeutic or cosmetic skincare agents are delivered to the skin with Invisicare®.

Skinvisible: How Do They Make Money?  What is Their Revenue Source

Skinvisible has four sources of revenue:

  1. Licensing Fees
  2. Research and Development Fees
  3. Sales of Polymers
  4. Royalties from Licensed Polymers

I think you are going to be impressed with the license agreements SKVI has under its belt — not to mention its national and international patents.

Whether you are new to Trading the StockGuru way or a veteran — I think you will recognize the pattern of value and potential here.

This weekend we will be delivering this to you in bite size pieces of information.  We realize you have a life and do not want to read a long treatise on a stock on a hot summer weekend.

But weekends can be a great time to bone up on a great investment.

Take the Skinvisible Journey with Stock Guru!

Skinvisible, Inc. / Skinvisible Pharmaceuticals, Inc.
6320 S. Sandhill Road, Suite 10
Las Vegas, Nevada, 89120 U.S.A.
Phone: 702.433.7154
Fax: 702.433.7192
Email: info@skinvisible.com

About Invisicare: Invisicare is Skinvisible’s patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. It is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time resisting both wash off and perspiration. Invisicare can control the release of actives, reduce irritation and can eliminate some costly manufacturing processes. It is non-occlusive and allows for normal skin respiration while protecting against environmental irritants. www.invisicare.com

About Skinvisible Pharmaceuticals, Inc.

Skinvisible is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing irritation. Skinvisible receives a combination of research and development fees, license fees, and royalties for the life of the patent. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare.

Forward Looking Statements: Certain statements, other than purely historical information, including estimates, projections, statements relating to SKVI business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. SKVI’s ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse affect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in other filings with the SEC.

StockGuru is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 – (469) 252-3030. Disclosure: StockGuru entered into an investor relations consulting and market awareness contract on July 12, 2010.  The company has agreed to pay us five thousand dollars per month in cash for the period of six months, totaling thirty thousand USD. StockGuru was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program.  This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. To further clarify, we will not be buying or selling shares for the period of July 12, 2010 through January 12, 2011. We hold no shares and will not be receiving further compensation that is share related during this period. StockGuru is not a registered investment adviser or a broker/dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Left Menu Icon
Right Menu Icon